These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 39062684

  • 1. Evaluating the Urinary Exosome microRNA Profile of von Hippel Lindau Syndrome Patients with Clear Cell Renal Cell Carcinoma.
    Walter-Rodriguez B, Ricketts CJ, Linehan WM, Merino MJ.
    Genes (Basel); 2024 Jul 11; 15(7):. PubMed ID: 39062684
    [Abstract] [Full Text] [Related]

  • 2. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.
    Gattolliat CH, Couvé S, Meurice G, Oréar C, Droin N, Chiquet M, Ferlicot S, Verkarre V, Vasiliu V, Molinié V, Méjean A, Dessen P, Giraud S, Bressac-De-Paillerets B, Gardie B, Tean Teh B, Richard S, Gad S.
    Int J Oncol; 2018 Oct 11; 53(4):1455-1468. PubMed ID: 30066860
    [Abstract] [Full Text] [Related]

  • 3. Urinary exosome miR-30c-5p as a biomarker of clear cell renal cell carcinoma that inhibits progression by targeting HSPA5.
    Song S, Long M, Yu G, Cheng Y, Yang Q, Liu J, Wang Y, Sheng J, Wang L, Wang Z, Xu B.
    J Cell Mol Med; 2019 Oct 11; 23(10):6755-6765. PubMed ID: 31342628
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney.
    Beroukhim R, Brunet JP, Di Napoli A, Mertz KD, Seeley A, Pires MM, Linhart D, Worrell RA, Moch H, Rubin MA, Sellers WR, Meyerson M, Linehan WM, Kaelin WG, Signoretti S.
    Cancer Res; 2009 Jun 01; 69(11):4674-81. PubMed ID: 19470766
    [Abstract] [Full Text] [Related]

  • 7. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
    Zhang W, Ni M, Su Y, Wang H, Zhu S, Zhao A, Li G.
    Eur Urol Focus; 2018 Apr 01; 4(3):412-419. PubMed ID: 28753793
    [Abstract] [Full Text] [Related]

  • 8. Growth characteristics and therapeutic decision markers in von Hippel-Lindau disease patients with renal cell carcinoma.
    Schuhmacher P, Kim E, Hahn F, Sekula P, Jilg CA, Leiber C, Neumann HP, Schultze-Seemann W, Walz G, Zschiedrich S.
    Orphanet J Rare Dis; 2019 Oct 28; 14(1):235. PubMed ID: 31661010
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Natural history of Von Hippel-Lindau disease-associated and sporadic clear cell renal cell carcinoma: a comparative study.
    Wang J, Zhang L, Qiu J, Li Z, Wu Y, Zhang C, Yao L, Gong K, Li X, Zhou L.
    J Cancer Res Clin Oncol; 2022 Oct 28; 148(10):2631-2641. PubMed ID: 34709473
    [Abstract] [Full Text] [Related]

  • 14. Beta-2-glycoprotein-1 and alpha-1-antitrypsin as urinary markers of renal cancer in von Hippel-Lindau patients.
    Mandili G, Notarpietro A, Khadjavi A, Allasia M, Battaglia A, Lucatello B, Frea B, Turrini F, Novelli F, Giribaldi G, Destefanis P.
    Biomarkers; 2018 Mar 28; 23(2):123-130. PubMed ID: 28004973
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-30a-5pme: a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples.
    Outeiro-Pinho G, Barros-Silva D, Aznar E, Sousa AI, Vieira-Coimbra M, Oliveira J, Gonçalves CS, Costa BM, Junker K, Henrique R, Jerónimo C.
    J Exp Clin Cancer Res; 2020 Jun 01; 39(1):98. PubMed ID: 32487203
    [Abstract] [Full Text] [Related]

  • 16. MiRNA-9 and MiRNA-200a distinguish hemangioblastomas from metastatic clear cell renal cell carcinomas in the CNS.
    Venneti S, Boateng LA, Friedman JR, Baldwin DA, Tobias JW, Judkins AR, Mourelatos Z, Lal P.
    Brain Pathol; 2012 Jul 01; 22(4):522-9. PubMed ID: 22082152
    [Abstract] [Full Text] [Related]

  • 17. VHL gene alterations in Italian patients with isolated renal cell carcinomas.
    Muscarella LA, D'Agruma L, la Torre A, Gigante M, Coco M, Parrella P, Battaglia M, Carrieri G, Carella M, Zelante L, Fazio VM, Gesualdo L, Ranieri E.
    Int J Biol Markers; 2013 Jun 28; 28(2):208-15. PubMed ID: 23558940
    [Abstract] [Full Text] [Related]

  • 18. von Hippel-Lindau mutants in renal cell carcinoma are regulated by increased expression of RSUME.
    Tedesco L, Elguero B, Pacin DG, Senin S, Pollak C, Garcia Marchiñena PA, Jurado AM, Isola M, Labanca MJ, Palazzo M, Yankilevich P, Fuertes M, Arzt E.
    Cell Death Dis; 2019 Mar 19; 10(4):266. PubMed ID: 30890701
    [Abstract] [Full Text] [Related]

  • 19. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC, Prowse AH, Affara NA, Buys CH, Maher ER.
    Genes Chromosomes Cancer; 1998 Jul 19; 22(3):200-9. PubMed ID: 9624531
    [Abstract] [Full Text] [Related]

  • 20. Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.
    Whaley JM, Naglich J, Gelbert L, Hsia YE, Lamiell JM, Green JS, Collins D, Neumann HP, Laidlaw J, Li FP.
    Am J Hum Genet; 1994 Dec 19; 55(6):1092-102. PubMed ID: 7977367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.